J3393
HCPCSInj, betibeglogene autotemce
Official HCPCS Level II long descriptor
Injection, betibeglogene autotemcel, per treatment
HCPCS Level II code J3393 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, betibeglogene autotemce
Added to HCPCS: 2024-07-01
Nearby codes in J3
- J3379Inj, valproate sod, 5 mg
- J3380Inj vedolizumab iv 1 mg
- J3385Velaglucerase alfa
- J3386Etuvetidigene autotemecel
- J3387Inj elivaldogene autotemecel
- J3389Topi adm prad zami per treat
- J3391Inj, atidarsagene autotemcel
- J3392Inj, exagamglogene autotem
- J3394Inj, lovotibeglogene autotem
- J3396Verteporfin injection
- J3397Inj., vestronidase alfa-vjbk
- J3398Inj luxturna 1 billion vec g
- J3399Inj onase abepar-xioi treat
- J3401Vyjuvek 5x10^9pfu/ml, 0.1 ml
- J3402Inj. remestemcel-l-rknd/ td
- J3403Revakinagene, per implant
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.